Trials / Completed
CompletedNCT05510479
Post-market Evaluation of OdySight App to Monitor Near Visual Acuity at Home (TIL002)
Post-market Study for At-home Evaluation of Near Visual Acuity With OdySight, a Smartphone Based Medical Application in Comparison to a Standardized Method (TIL002)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (actual)
- Sponsor
- Tilak Healthcare · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
OdySight is a mobile application allowing self-testing of visual parameters including near visual acuity and communication of the data to an online dashboard to patient's doctors. TIL-002 post-market clinical trial objective is to evaluate the near visual acuity at home, measured with OdySight application in comparison to the standardized methods. The clinical trial is intended to prove that OdySight can provide relevant data and participate in the remote monitoring of subject vision.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Software as medical device | At home measurements of visual acuity through a mobile app |
Timeline
- Start date
- 2021-05-05
- Primary completion
- 2022-05-11
- Completion
- 2022-05-11
- First posted
- 2022-08-22
- Last updated
- 2022-08-22
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05510479. Inclusion in this directory is not an endorsement.